TERT and glioma: Next, Prof. Yu Yao from Huashan Hospital of Fudan University reported the recent progress of his team in glioma immunology after stating the importance of genes encoding IDH1 and telomerase reverse transcriptase (TERT), as well as 1p/19q codeletion in classifying glioma [5].